Paraldehyde is a sedative and anticonvulsant drug that was widely used in hospitals and psychiatric wards throughout the early and mid-twentieth century. Chemically, it is a cyclic trimer of acetaldehyde, with the molecular formula C₆H₁₂O₃. While it has largely been replaced by newer medications, it still holds a niche role in certain medical settings, particularly for treating seizures that don’t respond to first-line drugs.
How Paraldehyde Works
Paraldehyde acts as a central nervous system depressant, slowing brain activity to produce sedation and stop seizures. Its exact mechanism isn’t fully understood, but researchers believe the drug itself is responsible for these effects rather than any breakdown products the body creates from it. This CNS-depressing action made it useful for calming agitation, inducing sleep, and controlling prolonged or treatment-resistant seizures.
What It Was Used For
Paraldehyde served several medical purposes over its long history. Its primary uses included treating refractory seizures and status epilepticus (a dangerous state of continuous seizure activity), managing alcohol withdrawal and delirium tremens, and providing sedation for severe insomnia. It was also used in cases of tetanus and eclampsia, a life-threatening seizure condition during pregnancy.
In psychiatric hospitals during the early 1900s, paraldehyde was one of the go-to sedatives alongside bromides and chloral hydrate. It was especially common on wards treating patients going through alcohol withdrawal. Nurses would administer it orally, rectally, or by injection, and the drug’s presence on a ward was impossible to miss because of its powerful, distinctive smell.
The Notorious Smell and Other Side Effects
The most recognizable feature of paraldehyde is the strong, unpleasant odor it gives to a patient’s breath. The smell was so pervasive that it could fill an entire hospital ward, and it lingered until about a day after the last dose. This “paraldehyde breath” became practically synonymous with the drug itself.
Beyond the odor, common side effects included drowsiness, nausea, vomiting, and stomach pain when taken by mouth. Some patients experienced dizziness, unsteadiness, and a hangover-like feeling. When given by injection, coughing and irritation at the injection site were frequent complaints. Long-term use could cause yellowing of the skin and eyes, a sign of liver stress. Like other CNS depressants, regular use could lead to tolerance and physical dependence, which created an ironic problem: some patients treated for alcohol addiction became dependent on paraldehyde instead.
In cases of overdose, paraldehyde could cause severe metabolic acidosis, a dangerous buildup of acid in the blood. This, combined with profound sedation and respiratory depression, made toxicity a serious and sometimes fatal concern.
The Glass Syringe Problem
One of paraldehyde’s quirks made it uniquely difficult to handle in a clinical setting. The liquid reacts with plastic and rubber, dissolving or extracting material from standard syringes and containers. Research published in the American Journal of Hospital Pharmacy found that plastic syringes and rubber plunger tips exposed to paraldehyde showed a significant increase in dissolved residue within just six hours. Because the nature of that extracted material was unknown, the recommendation was to use all-glass syringes whenever possible. If a plastic syringe had to be used, the drug needed to be administered immediately, with no time for the liquid to sit in contact with the plastic.
This storage and handling challenge added another layer of inconvenience to a drug that was already difficult to work with because of its odor and irritating properties.
Why It Fell Out of Use
Paraldehyde’s decline began in the early 1960s with the arrival of chlordiazepoxide (Librium) in 1960 and diazepam (Valium) in 1962. These benzodiazepines offered the same sedative and anticonvulsant benefits with a better safety profile, fewer side effects, and none of the odor or storage headaches. Within a relatively short period, benzodiazepines became the preferred choice for most physicians, and paraldehyde was increasingly viewed as obsolete.
The two biggest strikes against paraldehyde were its offensive smell, which made it unpopular with patients and staff alike, and the puzzling tendency for patients treated for alcohol withdrawal to develop paraldehyde dependence. The reasons for this cross-dependence were never fully explained, but it undercut the drug’s usefulness for one of its primary indications. The general medical consensus became that benzodiazepines were both more effective and safer than paraldehyde and the other older sedatives it had been grouped with.
Where Paraldehyde Still Appears
Despite being largely obsolete in the United States, paraldehyde has not entirely vanished from medicine. In some countries, particularly in parts of Africa and in certain UK hospitals, rectal paraldehyde remains a treatment option for prolonged seizures in children, especially when other anticonvulsants have failed or are unavailable. Its value in these settings comes from the fact that it doesn’t require refrigeration, works through a simple rectal route, and is inexpensive compared to alternatives.
In resource-limited settings where benzodiazepines may be in short supply or where intravenous access is difficult to establish quickly, paraldehyde fills a practical gap. It is a reminder that even drugs considered outdated in wealthier healthcare systems can still serve an important purpose elsewhere.